pBp-FGFR3c-WT Citations (1)
Originally described in: Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.Liao RG, Jung J, Tchaicha JH, Wilkerson MD, Sivachenko A, Beauchamp EM, Liu Q, Pugh TJ, Pedamallu CS, Hayes DN, Gray NS, Getz G, Wong KK, Haddad RI, Meyerson M, Hammerman PS Cancer Res. 2013 Jun 20. PubMed Journal
Articles Citing pBp-FGFR3c-WT
| Articles |
|---|
Glioblastoma Cell Resistance to EGFR and MET Inhibition Can Be Overcome via Blockade of FGFR-SPRY2 Bypass Signaling.
Day EK, Sosale NG, Xiao A, Zhong Q, Purow B, Lazzara MJ.
Cell Rep. 2020 Mar 10;30(10):3383-3396.e7. doi: 10.1016/j.celrep.2020.02.014.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.